René Kuijten, managing partner at Life Science Partners
February 11, 2022 11:04 AM ESTUpdated February 17, 11:15 AM
Financing

As it pre­pares to join EQT, Life Sci­ence Part­ners sur­pass­es €1B in­vest­ment mark

Josh Sullivan

Just a few months ago, the Eu­ro­pean in­vest­ment firm Life Sci­ence Part­ners an­nounced that it would be bought out by the pri­vate in­vest­ment group EQT …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times